Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Merkel Cell × avelumab × Clear all

Phase

Phase 2 9 Phase 1/2 7 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 4 Carcinoma, Transitional Cell 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Carcinoma, Renal Cell 2 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Neoplasm Metastasis 1 Microsatellite Instability 1 Lymphoma, Large B-Cell, Diffuse 1 Kidney Neoplasms 1 Kidney Diseases 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Merkel Cell 1

Interventions

pembrolizumab 1 cemiplimab 1 avelumab 1 atezolizumab 1 Saline Solution 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03271372 2025-09-17

ADAM

University of Washington

Phase 3 Active not recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡